RxDoctor Payments Data

Reza Malek, MD

Vascular & Interventional Radiology · Mountain View, CANPI 1891739348

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,872 of the $3,372 with a category attached, or 85.2%. It is spread thinly across 21 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $975 and has fallen 80.8% since, to $187 in 2025. That places this record below the midpoint for vascular & interventional radiology clinicians in CA, where the typical reported total is $2,952.

$3,372in general payments, 2019–2025

Across 56 payments — averaging $60.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$584
  • Medical Device Business Services, Inc.$500
  • Medtronic$457
  • Stryker$403
  • Penumbra, Inc.$227
  • Angiodynamics, Inc.$186
  • plus $1K from 15 others
$3,450in research payments, 2019–2025

Across 6 payments — averaging $575.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$3K
  • Medical Device Business Services, Inc.$500

What the payments were for

  • Consulting fees$50015%
  • Food & beverage$2,87285%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,372 in reported general payments places this provider in the 50th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California →

Medicare billing

Part B allowed, 2024
$111,602
Medicare patients
156
Services billed
555

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate16$381

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Mountain View

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →